35 results
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
IDSA Surgical Wound ... and treatment of ... patients with type 1 ... or linezolid, pending ... #Algorithm #IDSA
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Clostridium difficile infection ... Episode #Pharmacology ... #Management #CDiff
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Epidemiology: • #1 ... 10 mg/kg IV x 1 ... mg PO qd - If needing ... ciab549 #CDI #Cdiff ... #IDSA #gastroenterology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
Drugs for Treatment ... Tuberculosis Step 1 ... Tuberculosis #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Persistent UC Symptoms Despite 5-ASA Therapies
 • Assess for Drug Adherence
 • Disease Activity Assessment (bloody
• Assess for Drug ... Adherence • Disease Activity ... Colonoscopy • Rule-Out Infection ... , Cdiff Mild Colitis ... #Management #Algorithm
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table 1. ... Recommendations for the Treatment ... Clostridium difficile Infection ... in Adults #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... are contacts of infectious ... Step 1: Choose one ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pathophysiology: 1. ... drug use • Silicosis ... Tuberculosis: 1. ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pathophysiology: 1. ... drug use • Silicosis ... Tuberculosis: 1. ... TB #Diagnosis #Management ... #Treatment #ActiveTB